Comparison of efficacy and safety of secondary treatment with increased fesoterodine and with mirabegron combination with 4mg fesoterodine for those who still have moderate or more overactive bladder symptoms after initial treatment with 4mg fesoterodine: preliminary study

Trial Profile

Comparison of efficacy and safety of secondary treatment with increased fesoterodine and with mirabegron combination with 4mg fesoterodine for those who still have moderate or more overactive bladder symptoms after initial treatment with 4mg fesoterodine: preliminary study

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Sep 2013

At a glance

  • Drugs Fesoterodine (Primary) ; Mirabegron (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top